EMILY CHRISTENSEN: Open Payments
NPI 1629661053 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,228 in 151 payments from 19 companies in 2025. Trend: 2023 $2,194 · 2024 $2,424 · 2025 $2,228
Food & beverage: $2,228
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $493 |
| PFIZER INC. | 32 | $416 |
| AstraZeneca Pharmaceuticals LP | 16 | $339 |
| Novo Nordisk Inc | 12 | $190 |
| Amgen Inc. | 13 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $145 |
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $108 |
| Lundbeck LLC | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 2 | $34 |
Products named: AIRSUPRA, NURTEC ODT, VRAYLAR, UBRELVY, REXULTI, CAPLYTA, QULIPTA, ZAVZPRET.
Industry payments across AR — which companies pay providers there.
